Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome. (Q46627262)
Jump to navigation
Jump to search
scientific article published on 13 September 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome. |
scientific article published on 13 September 2016 |
Statements
Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome (English)
Christie M Ballantyne
Dirk J Blom
Michael J Koren
Eli Roth
Maria Laura Monsalvo
C Stephen Djedjos
Patric Nelson
Mary Elliott
Scott M Wasserman
14 October 2016
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference